Call Options

20 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$79.22 - $105.37 $4.98 Million - $6.63 Million
-62,900 Reduced 69.05%
28,200 $2.88 Million
Q1 2023

May 15, 2023

BUY
$30.85 - $93.17 $2.65 Million - $8 Million
85,900 Added 1651.92%
91,100 $8.28 Million
Q4 2022

Feb 14, 2023

SELL
$22.15 - $42.11 $598,050 - $1.14 Million
-27,000 Reduced 83.85%
5,200 $197,000
Q3 2022

Nov 14, 2022

BUY
$19.41 - $36.49 $479,427 - $901,303
24,700 Added 329.33%
32,200 $809,000
Q2 2022

Aug 08, 2022

BUY
$20.71 - $36.5 $155,325 - $273,750
7,500 New
7,500 $228,000
Q1 2022

May 16, 2022

SELL
$24.12 - $39.6 $48,240 - $79,200
-2,000 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$25.61 - $110.96 $56,342 - $244,112
-2,200 Reduced 52.38%
2,000 $53,000
Q3 2021

Nov 15, 2021

BUY
$100.0 - $143.02 $290,000 - $414,758
2,900 Added 223.08%
4,200 $423,000
Q2 2021

Aug 16, 2021

BUY
$78.27 - $151.29 $101,751 - $196,677
1,300 New
1,300 $184,000
Q4 2020

Feb 16, 2021

SELL
$102.03 - $184.62 $132,639 - $240,006
-1,300 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$93.53 - $163.34 $46,765 - $81,670
500 Added 62.5%
1,300 $127,000
Q2 2020

Aug 14, 2020

SELL
$126.3 - $176.56 $25,260 - $35,312
-200 Reduced 20.0%
800 $125,000
Q1 2020

May 15, 2020

SELL
$124.16 - $247.74 $856,704 - $1.71 Million
-6,900 Reduced 87.34%
1,000 $144,000
Q4 2019

Feb 14, 2020

BUY
$74.57 - $217.92 $536,904 - $1.57 Million
7,200 Added 1028.57%
7,900 $1.62 Million
Q3 2019

Nov 14, 2019

SELL
$71.26 - $95.75 $99,764 - $134,050
-1,400 Reduced 66.67%
700 $56,000
Q2 2019

Aug 14, 2019

SELL
$77.72 - $94.35 $7,772 - $9,435
-100 Reduced 4.55%
2,100 $198,000
Q1 2019

May 15, 2019

SELL
$51.9 - $101.79 $5,190 - $10,179
-100 Reduced 4.35%
2,200 $188,000
Q4 2018

Feb 14, 2019

BUY
$48.76 - $76.44 $4,876 - $7,644
100 Added 4.55%
2,300 $129,000
Q3 2018

Nov 14, 2018

BUY
$35.64 - $92.06 $74,844 - $193,326
2,100 Added 2100.0%
2,200 $180,000
Q2 2018

Aug 14, 2018

BUY
$19.94 - $40.96 $1,994 - $4,096
100 New
100 $3,000

Others Institutions Holding RETA

About REATA PHARMACEUTICALS INC


  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.